SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Harrow Health, Inc. 8.625% Senior Notes due 2026 HROWL NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $25.61. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 2 out of 7 criteria passed.

Financials: revenue is $272M, +45.6%/yr average growth. Net income is $5M (loss), growing at +8.6%/yr. Net profit margin is -1.9% (negative). Gross margin is 75.1% (+3.8 pp trend).

Balance sheet: total debt is $252M against $52M equity (Debt-to-Equity (D/E) ratio 4.8, leveraged). Current ratio is 2.2 (strong liquidity). Debt-to-assets is 63.1%. Total assets: $399M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 83/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 70/100 (Pass), Future ?/100 (Fail), Income 10/100 (Fail).

HROWL SharesGrow Score Overview

49/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 83/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 33/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 70/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — HROWL

No analyst coverage available for this stock.

HROWL: +45.6%/yr revenue is, +8.6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet HROWL: Debt-to-Equity (D/E) ratio 4.8 (leveraged), Current ratio is 2.2 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

HROWL: Gross margin is 75.1% (+3.8 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 70/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

HROWL: Net profit margin is -1.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range25-25.72

Volume7.66K

Avg Volume (30D)16.25K

Market Cap$1.37B

Beta (1Y)0.14

Dividend Yield$1.6172

Share Statistics

EPS (TTM)-0.14

Shares Outstanding$36.76M

IPO Date2021-05-07

Employees217

CEOMark L. Baum

Financial Highlights & Ratios

Revenue (TTM)$272.3M

Gross Profit$204.37M

EBITDA$56.08M

Net Income$-5.14M

Operating Income$36.4M

Total Cash$72.93M

Total Debt$251.98M

Net Debt$179.05M

Total Assets$399.48M

Price / Earnings (P/E)-182.9

Price / Sales (P/S)5.02

Analyst Forecast

Company Info

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS4158582084

Price Chart

HROWL

Harrow Health, Inc. 8.625% Senior Notes due 2026 ↗ · NASDAQ Global Market

Healthcare • Medical - Pharmaceuticals

25.00 52WK RANGE 25.72

People Also View

Babcock & Wilcox Enterprises, I

SiriusPoint Ltd.

B. Riley Financial, Inc. 6.00% Senior Notes Due 2028

B. Riley Financial, Inc. - 6.75

Babcock & Wilcox Enterprises, I

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message